Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

34,100

Employees34,100

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

34,100

Employees34,100

BMY Key Statistics

Market cap

89.21B

Market cap89.21B

Price-Earnings ratio

17.69

Price-Earnings ratio17.69

Dividend yield

5.61%

Dividend yield5.61%

Average volume

14.28M

Average volume14.28M

High today

—

High today—

Low today

—

Low today—

Open price

$44.31

Open price$44.31

Volume

0.00

Volume0.00

52 Week high

$63.33

52 Week high$63.33

52 Week low

$42.96

52 Week low$42.96

BMY News

Nasdaq 21h

Interesting BMY Put And Call Options For December 5th

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options become available today, for the December 5th expiration. At Stock Options Channel , our Yiel...

TipRanks 3d

Bristol-Myers Squibb: Hold Rating Amid Market Challenges and Uncertain Growth Prospects

Goldman Sachs analyst Asad Haider maintained a Hold rating on Bristol-Myers Squibb yesterday and set a price target of $51.00. Elevate Your Investing Strategy:...

Nasdaq 4d

Validea Detailed Fundamental Analysis - BMY

Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our P/B Growth Invest...

Analyst ratings

69%

of 29 ratings

Buy

27.6%

Hold

69%

Sell

3.4%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.